Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ripple Effects is a private U.S. company that develops evidence-based digital programs focused on social-emotional learning, behavioral intervention, and student mental health support for Pre-K through grade 12 settings. Its products are used by schools, districts, and youth-serving organizations to provide personalized skill-building, prevention, and intervention tools across MTSS, restorative settings, and special education support contexts. The company’s core offerings include Ripple Effects for Kids, Ripple Effects for Teens, Bouncy’s Ready to Learn Resilience for early learners, and Educator Ally for staff support. Although it is not a drug-development biotech or pharma company, it operates in the broader behavioral health and mental health support ecosystem through software and digital intervention products. The company emphasizes research-backed outcomes in academic performance, behavior, resiliency, and school engagement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ripple Effects.